CYANOKIT

This brand name is authorized in Austria, Croatia, Estonia, Finland, France, Hong Kong SAR China, Ireland, Japan, Lithuania, Netherlands, Poland, Spain, UK, United States.

Active ingredients

The drug CYANOKIT contains one active pharmaceutical ingredient (API):

1	Vitamin B12a UNII Q40X8H422O - HYDROXOCOBALAMIN
	Hydroxocobalamin is a cyanide antidote. Its action in the treatment of cyanide poisoning is based on its ability to bind cyanide ions. Each hydroxocobalamin molecule can bind one cyanide ion by substituting it for the hydroxo ligand linked to the trivalent cobalt ion, to form cyanocobalamin, which is then excreted in the urine.
	Read more about Vitamin B12a

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CYANOKIT Powder for solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V03AB33	Hydroxocobalamin	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes
Discover more medicines within V03AB33

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1327395, 1499519
ES	Centro de información online de medicamentos de la AEMPS	07420002
FI	Lääkealan turvallisuus- ja kehittämiskeskus	112073
FR	Base de données publique des médicaments	60232334
GB	Medicines & Healthcare Products Regulatory Agency	201767
HK	Department of Health Drug Office	62101
JP	医薬品医療機器総合機構	3929408D2021
LT	Valstybinė vaistų kontrolės tarnyba	1028354, 1057027
NL	Z-Index G-Standaard, PRK	101990
PL	Rejestru Produktów Leczniczych	100206550, 100236828
US	FDA, National Drug Code	11704-370